RADEK SKODA to Platelet-Derived Growth Factor
This is a "connection" page, showing publications RADEK SKODA has written about Platelet-Derived Growth Factor.
Connection Strength
0.039
-
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms. J Clin Invest. 2019 03 04; 129(4):1596-1611.
Score: 0.039
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.